ReviewThe international journal of neuropsychopharmacology2013
Biological substrates underpinning diagnosis of major depression.
Review in The international journal of neuropsychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review.International journal of molecular sciences · 2018Pooled it
- Molecular Characterization of the Progressive Landscape of Depression.bioRxiv : the preprint server for biology · 2026Article
- Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence.Journal of clinical medicine research · 2024Article
- Pathophysiology in cortico-amygdala circuits and excessive aversion processing: the role of oligodendrocytes and myelination.Brain communications · 2024Review
- Molecular characterization of depression trait and state.Molecular psychiatry · 2022Article
- Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.Brain, behavior, and immunity · 2020Article
- Differential gene regulatory pattern in the human brain from schizophrenia using transcriptomic-causal network.BMC bioinformatics · 2020Article
- Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder.European archives of psychiatry and clinical neuroscience · 2018Article
- Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions.Current behavioral neuroscience reports · 2018Article
- Sustained Molecular Pathology Across Episodes and Remission in Major Depressive Disorder.Biological psychiatry · 2018Article
- Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior.Biological psychiatry · 2018Article
- Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.Biological psychiatry · 2017Review
- Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.Psychopharmacology · 2016Article
- Current Problems in the Research and Development of more Effective Antidepressants.Shanghai archives of psychiatry · 2016Article
- Sex-related factors influence expression of mood-related genes in the basolateral amygdala differentially depending on age and stress exposure.Biology of sex differences · 2016Article
- Major depressive disorder: mechanism-based prescribing for personalized medicine.Neuropsychiatric disease and treatment · 2015Review
- A meta-analysis of lipid peroxidation markers in major depression.Neuropsychiatric disease and treatment · 2015Review
- Gene-environment interaction in major depression: focus on experience-dependent biological systems.Frontiers in psychiatry · 2015Review
- Article
- Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders.Genes, brain, and behavior · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Major depression is characterized by low mood, a reduced ability to experience pleasure and frequent cognitive, physiological and high anxiety symptoms. It is also the leading cause of years lost due to disability worldwide in women and men, reflecting a lifelong trajectory of recurring episodes, increasing severity and progressive treatment resistance. Yet, antidepressant drugs at best treat only one out of every two patients and have not fundamentally changed since their discovery by chance >50 yr ago. This status quo may reflect an exaggerated emphasis on a categorical disease classification that was not intended for biological research and on oversimplified gene-to-disease models for complex illnesses. Indeed, genetic, molecular and cellular findings in major depression suggest shared risk and continuous pathological changes with other brain-related disorders. So, an alternative is that pathological findings in major depression reflect changes in vulnerable brain-related biological modules, each with their own aetiological factors, pathogenic mechanisms and biological/environment moderators. In this model, pathological entities have low specificity for major depression and instead co-occur, combine and interact within individual subjects across disorders, contributing to the expression of biological endophenotypes and potentially clinical symptom dimensions. Here, we discuss current limitations in depression research, review concepts of gene-to-disease biological scales and summarize human post-mortem brain findings related to pyramidal neurons, γ-amino butyric acid neurons, astrocytes and oligodendrocytes, as prototypical brain circuit biological modules. Finally we discuss nested aetiological factors and implications for dimensional pathology. Evidence suggests that a focus on local cell circuits may provide an appropriate integration point and a critical link between underlying molecular mechanisms and neural network dysfunction in major depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.